A review of seamless phase I/II trial designs towards oncology dose optimization with examples of clinical pharmacology considerations in early drug development
This review article focuses on seamless Phase I/II designs for dose optimization in oncology and provides practical CP consideration examples in evaluating modern designs and ensures essential features to inform CP packages are included as part of the trial design in a cross-functional team setting.